Teisuke Takahashi - Concepedia

Author

Teisuke Takahashi

Taisho Pharmaceutical (Japan)

Also Known As

Teisuke Takahashi

Publications

796

Citations

H-Index

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)The University of Osaka University of Mississippi Medical Center Kanazawa University

About

Teisuke Takahashi is an author at Taisho Pharmaceutical (Japan) specializing in pharmacology, medicine, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	425
2	Anesthesia	2	2	35
3	Health Sciences	1	1	62
4	Natural Sciences	1	1	154
5	Biochemistry	1	1	154

Teisuke Takahashi

Publications

695

Citations

H-Index

Page 1

	Year	Citations
(1<i>S</i>)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-<scp>d</scp>-glucitol (TS-071) is a Potent, Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for Type 2 Diabetes Treatment Hiroyuki Kakinuma, Takahiro Oi, Yuko Hashimoto-Tsuchiya, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDiabetes ManagementBiochemistryCompound 3P	2010	154
Effects of a New SGLT2 Inhibitor, Luseogliflozin, on Diabetic Nephropathy in T2DN Rats Naoki Kojima, Jan M. Williams, Teisuke Takahashi, Journal of Pharmacology and Experimental Therapeutics	2013	140
Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia–reperfusion injuries Kenzo Takahashi, Teisuke Takahashi, Taizo Suzuki, European Journal of Pharmacology Myocardial Ischemia–reperfusion InjuriesCardiovascular DiseaseMedicinePhysiologyCardiovascular Pharmacology	2002	109
Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury Keiichi Hishikari, Jun‐ichi Suzuki, Masahito Ogawa, Cardiovascular Research	2008	73
Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats Naoki Kojima, Jan M. Williams, Tiffani Slaughter, Physiological Reports HypertensionRenal InflammationRat ModelBlood PressureOxidative Stress	2015	62
The specific Na+/Ca2+ exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells Tetsuaki Nashida, Kazuhiro Takuma, Sayoko Fukuda, Neurochemistry International Sh-sy5y CellsSignal TransductionReactive Nitrogen SpecieMedicineNitric Oxide-induced Cytotoxicity	2011	31
SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson’s disease Yukio Ago, Toshiyuki Kawasaki, Tetsuaki Nashida, Neuropharmacology Neurodegenerative DiseasesMedicineParkinson ’NeuropharmacologyNeuroprotection	2011	24
The role of endothelium-derived nitric oxide in acetylcholine-induced coronary vasoconstriction in closed-chest pigs Hiroshi Hata, Kensuke Egashira, Tohru Fukai, Coronary Artery Disease	1993	22
DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats Sota Kato, Teisuke Takahashi, Noriyuki Miyata, Journal of Pharmacology and Experimental Therapeutics	2019	20
Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs Teisuke Takahashi, Kenzo Takahashi, Michihito Onishi, European Journal of Pharmacology Myocardial StunningCardiac MuscleAnesthetized DogsMedicinePhysiology	2004	19

Page 1